Combined progesterone (IM + V) versus vaginal progesterone for luteal support in cleavage-stage embryo transfer cycles of good prognosis patients.

about

Combined progesterone (IM + V) versus vaginal progesterone for luteal support in cleavage-stage embryo transfer cycles of good prognosis patients.

Item

http://www.wikidata.org/entity/Q40144416

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Combined progesterone (IM + V) ...... es of good prognosis patients.

@en

type

Item

label

Combined progesterone (IM + V) ...... es of good prognosis patients.

@en

prefLabel

Combined progesterone (IM + V) ...... es of good prognosis patients.

@en

P1476

Combined progesterone (IM + V) ...... es of good prognosis patients.

@en

P2093

A Bostancı Durmus

http://www.w3.org/2001/XMLSchema#string

E G Pabuccu

http://www.w3.org/2001/XMLSchema#string

M Keskin

http://www.w3.org/2001/XMLSchema#string

O Evliyaoglu Ozdegirmenci

http://www.w3.org/2001/XMLSchema#string

R Pabuccu

http://www.w3.org/2001/XMLSchema#string

P2860

Examining the evidence: progesterone supplementation during fresh and frozen embryo transfer

Luteal phase support for frozen embryo transfer cycles: intramuscular or vaginal progesterone?

Improving the luteal phase after ovarian stimulation: reviewing new options.

Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization.

Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles.

Crinone vaginal gel is equally effective and better tolerated than intramuscular progesterone for luteal phase support in in vitro fertilization-embryo transfer cycles: a prospective randomized study.

Luteal-phase support in assisted reproduction treatment: real-life practices reported worldwide by an updated website-based survey.

Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertil

Administration of progesterone before oocyte retrieval negatively affects the implantation rate.

Progesterone support in IVF: is evidence-based medicine translated to clinical practice? A worldwide web-based survey

P304

366-369

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/09513590.2015.1127910

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26732029

http://www.w3.org/2001/XMLSchema#string